Supernus Pharmaceuticals, Inc. (SUPN)

51.30 -0.35 (-0.68%) USD  |  NASDAQ  |  Feb 09, 16:00
51.60 +0.30 (+0.58%) Pre-Market: 08:04
More

Supernus Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Moderna, Inc. Upgrade